These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 34742747)

  • 41. Lipid Nanoparticle Composition Drives mRNA Delivery to the Placenta.
    Young RE; Nelson KM; Hofbauer SI; Vijayakumar T; Alameh MG; Weissman D; Papachristou C; Gleghorn JP; Riley RS
    bioRxiv; 2022 Dec; ():. PubMed ID: 36597546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. pH-Dependent Phase Behavior and Stability of Cationic Lipid-mRNA Nanoparticles.
    Larson NR; Hu G; Wei Y; Tuesca AD; Forrest ML; Middaugh CR
    J Pharm Sci; 2022 Mar; 111(3):690-698. PubMed ID: 34774918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intracellular trafficking kinetics of nucleic acid escape from lipid nanoparticles via fluorescence imaging.
    M Bailey-Hytholt C; Ulinski G; Dugas J; Haines M; Lazebnik M; Piepenhagen P; E Zarraga I; Bandekar A
    Curr Pharm Biotechnol; 2023 Apr; ():. PubMed ID: 37016519
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs.
    Lokugamage MP; Vanover D; Beyersdorf J; Hatit MZC; Rotolo L; Echeverri ES; Peck HE; Ni H; Yoon JK; Kim Y; Santangelo PJ; Dahlman JE
    Nat Biomed Eng; 2021 Sep; 5(9):1059-1068. PubMed ID: 34616046
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lipid-nucleic acid nanoparticles of novel ionizable lipids for systemic BMP-9 gene delivery to bone-marrow mesenchymal stem cells for osteoinduction.
    Vhora I; Lalani R; Bhatt P; Patil S; Misra A
    Int J Pharm; 2019 May; 563():324-336. PubMed ID: 30954673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics.
    Gindy ME; Feuston B; Glass A; Arrington L; Haas RM; Schariter J; Stirdivant SM
    Mol Pharm; 2014 Nov; 11(11):4143-53. PubMed ID: 25317715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of a high-throughput platform for screening lipid nanoparticles for mRNA delivery.
    Cui L; Pereira S; Sonzini S; van Pelt S; Romanelli SM; Liang L; Ulkoski D; Krishnamurthy VR; Brannigan E; Brankin C; Desai AS
    Nanoscale; 2022 Jan; 14(4):1480-1491. PubMed ID: 35024714
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration.
    Carrasco MJ; Alishetty S; Alameh MG; Said H; Wright L; Paige M; Soliman O; Weissman D; Cleveland TE; Grishaev A; Buschmann MD
    Commun Biol; 2021 Aug; 4(1):956. PubMed ID: 34381159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent Advances in Lipid Nanoparticles for Delivery of mRNA.
    Yang L; Gong L; Wang P; Zhao X; Zhao F; Zhang Z; Li Y; Huang W
    Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559175
    [TBL] [Abstract][Full Text] [Related]  

  • 50. RGD peptide-based lipids for targeted mRNA delivery and gene editing applications.
    Qin J; Xue L; Gong N; Zhang H; Shepherd SJ; Haley RM; Swingle KL; Mitchell MJ
    RSC Adv; 2022 Sep; 12(39):25397-25404. PubMed ID: 36199352
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lung-Specific mRNA Delivery Enabled by Sulfonium Lipid Nanoparticles.
    Popoola DO; Cao Z; Men Y; Li X; Viapiano M; Wilkens S; Luo J; Teng Y; Meng Q; Li Y
    Nano Lett; 2024 Jul; 24(26):8080-8088. PubMed ID: 38888232
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Delivering mRNA to a human NK cell line, NK-92 cells, by lipid nanoparticles.
    Nakamura T; Nakade T; Sato Y; Harashima H
    Int J Pharm; 2023 Apr; 636():122810. PubMed ID: 36898618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction Kinetics of Individual mRNA-Containing Lipid Nanoparticles with an Endosomal Membrane Mimic: Dependence on pH, Protein Corona Formation, and Lipoprotein Depletion.
    Aliakbarinodehi N; Gallud A; Mapar M; Wesén E; Heydari S; Jing Y; Emilsson G; Liu K; Sabirsh A; Zhdanov VP; Lindfors L; Esbjörner EK; Höök F
    ACS Nano; 2022 Dec; 16(12):20163-20173. PubMed ID: 36511601
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ready-to-Use-Type Lyophilized Lipid Nanoparticle Formulation for the Postencapsulation of Messenger RNA.
    Tanaka H; Hagiwara S; Shirane D; Yamakawa T; Sato Y; Matsumoto C; Ishizaki K; Hishinuma M; Chida K; Sasaki K; Yonemochi E; Ueda K; Higashi K; Moribe K; Tadokoro T; Maenaka K; Taneichi S; Nakai Y; Tange K; Sakurai Y; Akita H
    ACS Nano; 2023 Feb; 17(3):2588-2601. PubMed ID: 36719091
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA.
    Ball RL; Hajj KA; Vizelman J; Bajaj P; Whitehead KA
    Nano Lett; 2018 Jun; 18(6):3814-3822. PubMed ID: 29694050
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel piperazine-based ionizable lipid nanoparticles allow the repeated dose of mRNA to fibrotic lungs with improved potency and safety.
    Kim M; Jeong M; Lee G; Lee Y; Park J; Jung H; Im S; Yang JS; Kim K; Lee H
    Bioeng Transl Med; 2023 Nov; 8(6):e10556. PubMed ID: 38023699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ionizable Lipid Nanoparticle-Mediated Delivery of Plasmid DNA in Cardiomyocytes.
    Scalzo S; Santos AK; Ferreira HAS; Costa PA; Prazeres PHDM; da Silva NJA; Guimarães LC; E Silva MM; Rodrigues Alves MTR; Viana CTR; Jesus ICG; Rodrigues AP; Birbrair A; Lobo AO; Frezard F; Mitchell MJ; Guatimosim S; Guimaraes PPG
    Int J Nanomedicine; 2022; 17():2865-2881. PubMed ID: 35795081
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aerosolizable Lipid Nanoparticles for Pulmonary Delivery of mRNA through Design of Experiments.
    Zhang H; Leal J; Soto MR; Smyth HDC; Ghosh D
    Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33143328
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimized microfluidic formulation and organic excipients for improved lipid nanoparticle mediated genome editing.
    Palanki R; Han EL; Murray AM; Maganti R; Tang S; Swingle KL; Kim D; Yamagata H; Safford HC; Mrksich K; Peranteau WH; Mitchell MJ
    Lab Chip; 2024 Aug; 24(16):3790-3801. PubMed ID: 39037068
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics.
    Mukai H; Ogawa K; Kato N; Kawakami S
    Drug Metab Pharmacokinet; 2022 Jun; 44():100450. PubMed ID: 35381574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.